Xeris Biopharma Holdings (XERS) FCF Margin (2020 - 2026)
Xeris Biopharma Holdings' FCF Margin came in at 8.97% for Q2 2026, up 8.72 percentage points from 0.25% a year earlier but down 2.90 percentage points from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) FCF Margin (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Xeris Biopharma Holdings reported FCF Margin of 16.88%, up 23.45 percentage points year-over-year; for FY2025, it came in at 9.81%, up 28.02 percentage points from FY2024.
- FCF Margin has increased in each of the last five years, with a five-year change of +405.87 percentage points (FY2020 to FY2025).
- Going back by year, FCF Margin was -18.21% in FY2024 (+10.48 pp), -28.69% in FY2023 (+64.64 pp), -93.33% in FY2022 (+101.51 pp) and -194.84% in FY2021 (+201.22 pp).
- The five-year range for quarterly FCF Margin is -219.31% (Q1 2022) to 24.78% (Q3 2025).
- Year-over-year, FCF Margin has increased for six consecutive quarters, with an average year-over-year change of +19.23 percentage points over the last eight quarters.
- The fastest year-over-year change in FCF Margin over five years came in Q3 2022 (a gain of 144.71 percentage points), and the weakest in Q4 2024 (a drop of 13.54 percentage points).
- Business Quant data shows XERS's FCF Margin at 11.87% (Q1 2026), 23.36% (Q4 2025) and 24.78% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | Xeris Biopharma Holdings | 1.71 Bn | 1.27 Bn | 79.59 Mn | 8.97% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.97% |
| Mar 31, 2026 | 11.87% |
| Dec 31, 2025 | 23.36% |
| Sep 30, 2025 | 24.78% |
| Jun 30, 2025 | 0.25% |
| Mar 31, 2025 | -16.69% |
| Dec 31, 2024 | 3.29% |
| Sep 30, 2024 | -15.30% |
| Jun 30, 2024 | -21.53% |
| Mar 31, 2024 | -49.96% |
| Dec 31, 2023 | 16.83% |
| Sep 30, 2023 | -30.24% |
| Jun 30, 2023 | -36.16% |
| Mar 31, 2023 | -78.74% |
| Dec 31, 2022 | -48.63% |
| Sep 30, 2022 | -59.73% |
| Jun 30, 2022 | -81.44% |
| Mar 31, 2022 | -219.31% |
| Dec 31, 2021 | -135.69% |
| Sep 30, 2021 | -204.44% |
API Access
Xeris Biopharma Holdings FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();